Transgenic animals in cardiovascular disease research
- PMID: 11187966
Transgenic animals in cardiovascular disease research
Abstract
Worldwide, the highest morbidity and mortality results from such cardiovascular diseases as hypertension, myocardial infarction, cardiac and renal failure, as well as stroke. Since the cardiovascular system and its regulation is quite complex, study of these disorders has been grossly limited to whole organism models. As a result, in recent years, transgenic technology has played a significant role in the discovery of specific gene products for cardiovascular regulation and disease aetiology. Genetic manipulation in rats and mice has altered the expression of numerous genes. In this review, some of the important new genetically modified animals (i.e. transgenic models) with alterations in hormone and second messenger systems involved in cardiovascular regulation are summarized.
Similar articles
-
[A transgenic animal model: new possibilities for cardiovascular research].Z Kardiol. 1995;84 Suppl 4:17-32. Z Kardiol. 1995. PMID: 8585270 Review. German.
-
Rat models of cardiovascular diseases.Methods Mol Biol. 2010;597:403-14. doi: 10.1007/978-1-60327-389-3_27. Methods Mol Biol. 2010. PMID: 20013248 Review.
-
[Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases].Nephrologie. 1998;19(7):385-9. Nephrologie. 1998. PMID: 9857372 Review. French.
-
Urotensin II: a cardiovascular and renal update.Curr Opin Nephrol Hypertens. 2008 Mar;17(2):199-204. doi: 10.1097/MNH.0b013e3282f49566. Curr Opin Nephrol Hypertens. 2008. PMID: 18277155 Review.
-
Transgenic animals in hypertension and cardiovascular research.Exp Nephrol. 1993 Jan-Feb;1(1):3-12. Exp Nephrol. 1993. PMID: 8081950 Review. No abstract available.
Cited by
-
Self-organization phenomena in embryonic stem cell-derived embryoid bodies: axis formation and breaking of symmetry during cardiomyogenesis.Cells Tissues Organs. 2012;195(5):377-91. doi: 10.1159/000328712. Epub 2011 Aug 19. Cells Tissues Organs. 2012. PMID: 21860211 Free PMC article.
-
Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model.PLoS One. 2019 Aug 12;14(8):e0220837. doi: 10.1371/journal.pone.0220837. eCollection 2019. PLoS One. 2019. PMID: 31404095 Free PMC article.
-
Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat.Physiol Rep. 2020 May;8(10):e14448. doi: 10.14814/phy2.14448. Physiol Rep. 2020. PMID: 32441493 Free PMC article.
-
Transgenesis in Drug Discovery: Enhancing Target Identification and Validation.Mol Biotechnol. 2025 Mar 27. doi: 10.1007/s12033-025-01426-4. Online ahead of print. Mol Biotechnol. 2025. PMID: 40148722 Review.
-
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.Neurochem Res. 2019 Jun;44(6):1323-1329. doi: 10.1007/s11064-018-2679-4. Epub 2018 Nov 15. Neurochem Res. 2019. PMID: 30443713 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Research Materials